Expediting Fentanyl Analogue Scheduling and Research for Life-Saving Treatments.
This Act aims to accelerate the response to the opioid crisis by mandating rapid classification of new, dangerous fentanyl-related substances by the government. Crucially, it streamlines the process for researchers to study these highly controlled substances, which is essential for developing new, life-saving antidotes and addiction treatments. Citizens benefit from quicker legal action against new drugs and increased potential for effective therapies.
Key points
Sets strict deadlines (1 or 3 years) for completing scientific evaluations and legal scheduling of new fentanyl analogues to quickly control their distribution.
Simplifies registration requirements for researchers studying Schedule I substances (including fentanyl), aiming to speed up the development of addiction treatments and antidotes.
Requires the public disclosure of scientific evaluations related to substance scheduling decisions, ensuring greater transparency.
Expired
Citizen Poll